Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals

$0.625 0.005 (0.81%)

High $0.63	Low $0.59	Trades 32	Turnover $33,720	Volume 55,179
30 June 2023 at 4:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code RCE	Name Recce Pharmaceuticals Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Pharmaceuticals	GIC Sub Industry Pharmaceuticals
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 305,520,071	Shares Floated 207,234,623	Held by Insiders 41.47%	Held by Institutions 13.939%

Directors & Officers

Name & Education	Position
Dr. John K. A. Prendergast Ph.D.	Executive Chairman of the Board
Mr. James Hamilton-Bray Graham GAICD	CEO, MD & Executive Director
Ms. Michele Keryn Dilizia BA (Journ), BSc (Med Sci)	Chief Scientific Director & Executive Director
Dr. Justin Ward	Principal Quality Chemist & Executive Director
Mr. Arthur Kollaras	Principal Engineer & Head of Manufacturing
Dr. Alan W. Dunton B.Sc., M.D.	Chief Medical Advisor & Independent Non Executive Director
Mr. Justin Reynolds	Chief Financial Officer
Mr. Daniel Astudillo B.A., B.Com., M.B.A.	Head of Marketing
Ms. Maggie Niewidok	Company Secretary

RCE Historic Dividends

Date	Amount
We found no dividends on record for RCE.

End of Day Prices

Date	Close	Volume	Change
03-Aug	$0.38	120,803	+0.01 (2.70%)
31-Jul	$0.37	29,912	-0.01 (1.33%)
30-Jul	$0.38	55,543	+0.01 (2.74%)
29-Jul	$0.37	35,714	0.00 (0.00%)
28-Jul	$0.37	34,989	-0.01 (2.67%)
27-Jul	$0.38	134,821	+0.02 (4.17%)
24-Jul	$0.36	65,425	0.00 (0.00%)
23-Jul	$0.36	213,680	+0.01 (2.86%)
22-Jul	$0.35	186,448	-0.02 (5.41%)
21-Jul	$0.37	144,692	+0.01 (2.78%)
20-Jul	$0.36	416,858	-0.02 (5.26%)
17-Jul	$0.38	155,988	-0.01 (2.56%)
18-Sep	$0.39	101,248	-0.02 (4.88%)
12-Sep	$0.41	166,268	0.00 (0.00%)
11-Sep	$0.41	718,012	-0.01 (1.20%)
5 up, 7 down, and 3 flat days

Market Cap (3-Aug) $116,097,624	EBITDA -	PE 0.00	Book Value $-0.06
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.11	Profit Margin N/A
Operating Margin -3813.48%	ROA 581.01%	ROE 1277.63%	Revenue (FY) $974,559
Revenue per Share $0.00	Gross Profit (FY) $-11,180,014	Q' YOY Revenue Growth 94.1%	Q' YOY Earnings Growth -

Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

RCE Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Recce Pharmaceuticals Ltd Health Care Blood Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

RCE Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals